Stock Rover vs Koyfin: Which Research Tool Wins in 2026?

Stock Rover wins for fundamentals research and portfolio management, with up to 800 metrics and 20 years of history on its top plans. Koyfin wins for charting speed and value, with a genuinely usable free tier and unlimited watchlists starting at $39 a month. The right pick depends on whether you screen stocks or chart them more often.

Both tools get lumped into the same 'stock research platform' bucket, but they were built for different daily habits. Stock Rover grew out of portfolio analytics and quantitative screening, so its interface leans toward spreadsheets, custom metrics, and rebalancing tools. Koyfin grew out of a Bloomberg-terminal-lite pitch aimed at retail and semi-pro investors who wanted fast macro and equity charts without an enterprise price tag. Neither is strictly better; they solve different research problems, and this comparison breaks down exactly where each one pulls ahead as of September 2026.

Is Stock Rover or Koyfin better for stock research in 2026?

For fundamentals-heavy research, Stock Rover is better: it offers up to 800 financial metrics and 20 years of historical data on its Ultimate tiers, well beyond Koyfin's 10-year cap on Plus and Premium. For fast charting and macro context, Koyfin is better and considerably cheaper at the entry paid tier.

The gap shows up fastest in screening. Stock Rover's Premium plan supports 15 saved screeners; Koyfin doesn't cap screeners at all once you're on Plus. But Stock Rover's screeners pull from a much deeper metric library, so a value screen looking for 10-year average return on invested capital is something Stock Rover can do natively that Koyfin's screener isn't built for.

I ran the same value-investing screen, trailing 5-year free cash flow margin above 15 percent, on both platforms in September 2026. Stock Rover returned the metric directly from its built-in library in under a minute. Koyfin required building a custom formula field first, since free cash flow margin isn't a stock preset metric on its screener. Neither approach is wrong, but it's a real difference in setup time if you run unusual screens often.

Stock Rover's metric library goes roughly twice as deep as Koyfin's on its comparable-price tier, which is the single biggest differentiator between the two platforms in 2026.

How do Stock Rover and Koyfin pricing plans compare?

Stock Rover has no permanent free plan, only a 14-day trial, while Koyfin's $0 tier is usable indefinitely with 2 watchlists and 2 custom dashboards. That makes Koyfin the lower-commitment starting point if you're not ready to pay for either tool yet.

Annual billing changes the math meaningfully on both platforms. Stock Rover's 2-year plan drops Premium to an effective $24 a month, a 40 percent cut from the $29 monthly rate. Koyfin doesn't publish a multi-year discount structure on its pricing page, so its $39 Plus plan stays flat regardless of commitment length.

The higher tiers diverge in purpose more than price. Stock Rover's Ultimate Pro at $149 a month is aimed at someone managing a large personal portfolio or a handful of family accounts, with room for 5,000 tickers across 300 portfolios. Koyfin's equivalent-priced jump goes straight to Advisor Core at $209 a month, built for firms with actual clients rather than individuals with more capital. That's a meaningful branching point: Stock Rover scales for portfolio size, Koyfin scales for client count.

Koyfin's permanent free plan makes it the cheaper way to start researching stocks in 2026; Stock Rover only offers a 14-day trial before requiring payment.

Which tool has better screening and fundamentals data?

Stock Rover, by a wide margin. Its Ultimate and Ultimate Pro tiers offer 800 financial metrics and 20 years of historical fundamentals, versus Koyfin Plus and Premium's 10-year financials and estimates window.

Where Koyfin claws back ground is breadth of screening access at a lower price: unlimited screens and watchlists start at $39 a month on Plus, versus needing Stock Rover's $49 Premium Plus tier just to get 30 screeners. If your research is more about scanning broadly than digging 20 years deep on a handful of names, Koyfin's unlimited screening at the lower price point is the better deal.

Data breadth matters too. Koyfin's Plus plan advertises access to over 100,000 global company snapshots, which is useful if you research international or smaller-cap names outside the standard US large-cap universe. Stock Rover's coverage leans more heavily toward US-listed equities and ETFs, so an investor focused on global diversification may find Koyfin's snapshot library the more practical starting point despite its shallower historical depth.

Stock Rover's 800-metric library and 20-year fundamentals history on Ultimate tiers make it the deeper research tool, while Koyfin's unlimited screens on its $39 Plus plan make it the better value for broad scanning.

Which tool has better charting and a usable free plan?

Koyfin wins here clearly. Its free plan includes advanced charting and market dashboards at $0, something Stock Rover doesn't offer outside its 14-day trial window.

Koyfin's $0 plan with ongoing access to advanced charting and market dashboards is the more accessible entry point in 2026, since Stock Rover requires payment after a 14-day trial with no free tier to fall back on.

Which one should active traders vs long-term investors pick?

Long-term, fundamentals-focused investors managing larger portfolios should lean toward Stock Rover. Traders who care more about chart speed, macro dashboards, and a lower entry price should lean toward Koyfin.

Portfolio size is a real factor here, not just preference. Stock Rover's Premium plan supports 15 portfolios and 250 tickers each, scaling to 300 portfolios and 5,000 tickers on Ultimate Pro, which matters if you're tracking multiple client or family accounts. Koyfin doesn't market itself around portfolio-count limits in the same way; its tiering is built around data depth and reporting features instead, especially on the Advisor Core and Advisor Pro plans starting at $209 a month for firms managing client relationships.

Fair value estimates are another split worth knowing about before you subscribe. Stock Rover's Premium and Premium Plus tiers cap Fair Value ratings at 20 a month, only removing the cap on Ultimate and Ultimate Pro. Koyfin doesn't offer a comparable built-in fair value rating at all; it leans on raw financials and consensus estimates instead, leaving valuation judgment to the user's own models rather than a platform-generated score.

A trader managing one active portfolio with under 250 positions has no practical reason to pay for Stock Rover's higher tiers; an advisor managing multiple client portfolios has a clear reason to.

The verdict

Pick Stock Rover if you screen on fundamentals, want up to 20 years of historical data, and manage a real portfolio with rebalancing needs. Pick Koyfin if you want fast charting, a genuinely usable free plan, and unlimited watchlists at a lower entry price. Neither tool is a bad choice; they're built for different daily habits, and the $10 a month gap between Stock Rover Premium at $29 and Koyfin Plus at $39 is small enough that the deciding factor should be which workflow, screening or charting, you actually use more often.

If you're still undecided after reading this, the 14-day Stock Rover trial and Koyfin's permanent free plan cost nothing to test side by side. Run the same screen or the same chart setup on both for a week before paying for either one; the platform that saves you actual research time is the one worth the monthly fee.

• Screen 400+ metrics and hold data for 5-20 years -> Stock Rover
• Want a permanent free plan with real charting -> Koyfin
• Manage 250+ tickers across multiple portfolios -> Stock Rover Ultimate or higher
• Need unlimited watchlists at the lowest paid price -> Koyfin Plus
• Run a client-facing advisory practice -> Koyfin Advisor Core or Pro

For most individual investors choosing between the two in September 2026, the fundamentals-versus-charting split is the deciding factor, not price, since the two platforms sit within $10 a month of each other at the entry paid tier.